HMOX1 and colitis: Administration of the HO-1 inhibitor zinc protoporphyrin IX blunts resolution of DSS-induced intestinal inflammation, as well as M2 macrophage polarization, suggesting a beneficial role for the Nrf2–HO-1 axis in attenuating colitis via immune function control [151].